CLINICAL_TRIALS
trial_result
· 2018-09-11
Clinical Trial Update: Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching [Phase 4]
Summary
A Phase 4 clinical trial evaluating a long-acting antihistamine for opioid-induced itching has been terminated with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Virginia Commonwealth University | Conditions: Pruritus | Phase 4 | Status: TERMINATED | Results posted: 2018-09-11